Published in Int J Epidemiol on October 01, 2001
From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol (2010) 3.46
Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J Virol (2003) 1.26
The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci (2013) 1.18
Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination. BMC Infect Dis (2015) 1.03
Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya. BMC Infect Dis (2009) 0.93
Polio elimination in Nigeria: A review. Hum Vaccin Immunother (2016) 0.75
Commentary: Cuba libre de poliovirus. Int J Epidemiol (2001) 0.75
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol (2000) 3.99
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res (1995) 2.98
Circumferential mucosectomy (stapled haemorrhoidectomy) versus conventional haemorrhoidectomy: randomised controlled trial. Lancet (2000) 2.96
Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81
Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet (1996) 2.78
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis (1996) 2.55
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Measles vaccination and Guillain-Barré syndrome. Lancet (1997) 2.36
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16
Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev (2000) 2.06
Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis (1999) 2.03
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med (1991) 1.92
Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg (1990) 1.91
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
The neurobehavioural rating scale: assessment of the behavioural sequelae of head injury by the clinician. J Neurol Neurosurg Psychiatry (1987) 1.79
New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum (1997) 1.78
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus Res (1998) 1.74
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Barriers to medical care of Mexican-Americans: the role of social class, acculturation, and social isolation. Med Care (1982) 1.71
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67
Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol (1999) 1.62
Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2. Virus Res (1998) 1.61
Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Role of superficial venous surgery in patients with combined superficial and segmental deep venous reflux. Eur J Vasc Endovasc Surg (2003) 1.51
Scalp tumour as a sign of systemic B-cell lymphoma. J Eur Acad Dermatol Venereol (2004) 1.48
Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis (1996) 1.47
Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol (2000) 1.44
Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection. Nucl Med Commun (2003) 1.41
Vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 1.39
Prediction of the behaviour of a single flow-injection manifold. Talanta (1985) 1.39
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. J Infect Dis (1997) 1.33
The surveillance challenge: final stages of eradication of poliomyelitis in the Americas. MMWR CDC Surveill Summ (1992) 1.27
Neurobehavioral outcome 1 year after severe head injury. Experience of the Traumatic Coma Data Bank. J Neurosurg (1990) 1.25
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25
Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis (1994) 1.21
Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20
Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Bull World Health Organ (1994) 1.20
Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis (2001) 1.20
Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater. J Infect Dis (1993) 1.19
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods (1993) 1.19
Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18
Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis (1997) 1.17
Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis (1999) 1.16
Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. J Infect Dis (1994) 1.15
Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002). Cardiovasc J Afr (2008) 1.15
Detection of astrovirus in pediatric stool samples by immunoassay and RNA probe. J Clin Microbiol (1991) 1.14
Biopsy-induced arteriovenous fistula and venous aneurysm in a renal transplant. Nephrol Dial Transplant (1998) 1.14
Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol (1999) 1.14
Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J (1996) 1.13
Review of regional measles surveillance data in the Americas, 1996-99. Lancet (2000) 1.13
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus (2006) 1.09
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile. Pediatr Infect Dis J (1996) 1.08
Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol (1998) 1.08
A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part I. Evaluation of the antimalarial activity of plants used by the Chacobo Indians. J Ethnopharmacol (2000) 1.07
Certification of the eradication of indigenous transmission of wild poliovirus in the Americas. J Infect Dis (1997) 1.07
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol (1998) 1.07
Strategies to eradicate rubella in the English-speaking Caribbean. Am J Public Health (2000) 1.05
A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol (1990) 1.05
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04
Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults. Ann Intern Med (1993) 1.03
Adaptive radiation of Espeletia in the cold andean tropics. Trends Ecol Evol (1991) 1.03